NO955172L - Delesjonsvarianter av protein S med manglende C4BP-bindingsaktivitet, men med APC-kofaktoraktivitet, samt materiale og terapeutiske metoder - Google Patents

Delesjonsvarianter av protein S med manglende C4BP-bindingsaktivitet, men med APC-kofaktoraktivitet, samt materiale og terapeutiske metoder

Info

Publication number
NO955172L
NO955172L NO955172A NO955172A NO955172L NO 955172 L NO955172 L NO 955172L NO 955172 A NO955172 A NO 955172A NO 955172 A NO955172 A NO 955172A NO 955172 L NO955172 L NO 955172L
Authority
NO
Norway
Prior art keywords
protein
lack
well
activity
c4bp
Prior art date
Application number
NO955172A
Other languages
English (en)
Norwegian (no)
Other versions
NO955172D0 (no
Inventor
Rogier Maria Bertina
Bonno Nammen Bouma
Original Assignee
Univ Leiden
Bonno Nammen Bouma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leiden, Bonno Nammen Bouma filed Critical Univ Leiden
Publication of NO955172D0 publication Critical patent/NO955172D0/no
Publication of NO955172L publication Critical patent/NO955172L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO955172A 1993-06-30 1995-12-20 Delesjonsvarianter av protein S med manglende C4BP-bindingsaktivitet, men med APC-kofaktoraktivitet, samt materiale og terapeutiske metoder NO955172L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93201906 1993-06-30
PCT/NL1994/000149 WO1995001433A1 (en) 1993-06-30 1994-06-28 Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods

Publications (2)

Publication Number Publication Date
NO955172D0 NO955172D0 (no) 1995-12-20
NO955172L true NO955172L (no) 1996-02-16

Family

ID=8213942

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955172A NO955172L (no) 1993-06-30 1995-12-20 Delesjonsvarianter av protein S med manglende C4BP-bindingsaktivitet, men med APC-kofaktoraktivitet, samt materiale og terapeutiske metoder

Country Status (7)

Country Link
US (2) US5663142A (de)
EP (1) EP0706564A1 (de)
JP (1) JPH08511948A (de)
AU (1) AU6985594A (de)
FI (1) FI956352A (de)
NO (1) NO955172L (de)
WO (1) WO1995001433A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863896A (en) 1995-11-09 1999-01-26 Immuno Ag Evaluation of substances for altering and for increasing APC response
SE9604378D0 (sv) * 1996-11-27 1996-11-27 Tac Ab Methods and reagents for determining protein S
SE9701228D0 (sv) * 1997-04-03 1997-04-03 Bjoern Dahlbaeck Rekombinanta protein-C-och protein-S-varianter
AU2003277034A1 (en) * 2002-09-30 2004-04-23 Socratech L.L.C. Protein s protects the nervous system from injury
US20070142272A1 (en) * 2003-01-24 2007-06-21 Zlokovic Berislav V Neuroprotective activity of activated protein c independent of its anticoagulant activity
BRPI0409497A (pt) * 2003-04-18 2006-05-02 Novartis Ag métodos e composições que alvejam tirosina cinases para a diagnose e tratamento de osteoartrite
JP2008507561A (ja) * 2004-07-23 2008-03-13 ザ ユニバーシティ オブ ロチェスター 活性化プロテインｃによる、脳内のプラスミノゲン活性化因子の不都合な作用の阻害
MX2015011873A (es) * 2013-03-15 2016-01-25 Bayer Healthcare Llc Dominios gla como agentes de direccionamiento.
AU2018328223A1 (en) 2017-09-05 2020-03-12 GLAdiator Biosciences, Inc. Delivery of payloads to stem cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5321123A (en) * 1991-07-02 1994-06-14 The Scripps Research Institute Protein S polypeptides and anti-peptide antibodies that inhibit protein S binding to C4B binding protein, diagnostic systems and therapeutic methods
US5405946A (en) * 1992-12-02 1995-04-11 The Scripps Research Institute Recombinant protein S variants deficient in C4BP binding activity, compositions and therapeutic methods

Also Published As

Publication number Publication date
US5656484A (en) 1997-08-12
JPH08511948A (ja) 1996-12-17
WO1995001433A1 (en) 1995-01-12
AU6985594A (en) 1995-01-24
US5663142A (en) 1997-09-02
FI956352A (fi) 1996-02-28
NO955172D0 (no) 1995-12-20
FI956352A0 (fi) 1995-12-29
EP0706564A1 (de) 1996-04-17

Similar Documents

Publication Publication Date Title
DK0397633T3 (da) Fibronectinbindende protein samt fremstilling deraf
NO975435L (no) Modifiserte/kimeriske proteiner samt anvendelse derav
DE69922822D1 (de) Rekombinante haarbehandlungsmittel
EP0849361A3 (de) Neue Liganden des Neuropeptide Rezeptors HFGAN72
DK244289A (da) Fibronectinbindende protein, dets anvendelse og fremstilling samt midler til brug ved fremstillingen
SE8902532L (sv) Bestaemning av plasmaproteiner
NO955172L (no) Delesjonsvarianter av protein S med manglende C4BP-bindingsaktivitet, men med APC-kofaktoraktivitet, samt materiale og terapeutiske metoder
DK0754229T3 (da) Afamin: et humant serum albumin-lignende protein
NO20014417L (no) Vaskul¶re adhesjonsmolekyler samt modulering av deres funksjon
EP0716591A4 (de) Verfahren und Präparat zum Binden von TAU und MAP2c Proteinen
EP0319315A3 (de) Von Willebrand-Faktor, welcher den Faktor VIII verbindet
DE69607034T2 (de) Pcna bindende substanz
NO922421D0 (no) Collagenbindende protein, samt fremstilling derav
AU2932100A (en) Neurodegenerative disorder related gene
ATE271125T1 (de) Neuartige tyrosinkinase
DE69737476D1 (de) Neuer galaninrezeptor
ATE316136T1 (de) Nierenpolycystose-gen
WO1997014966B1 (en) Method of activating a novel ligand regulatory pathway
ATE103979T1 (de) Menschliches lymphotoxin.
WO1999030670A3 (en) Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof